interleukin-2
-
Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2: an Outcome Study
Edith Huland, A. Burger, J. Fleischer, P. Fornara, E. Hatzmann, A. Heidenreich, H. Heinzer, H. Heynemann, L. Hoffmann, R. Hofmann, H. Huland, I. Kämpfer, M. Kindler, H. Kirchner, G. Mehlhorn, T. H. Moniak, U. Rebmann, J. Roigas, T. H. Schneider, D. Schnorr, H.-J. Schmitz, R. Wenisch, Z. Varga, J. Vinke
2003, Vol. 49, Issue 5, pp. 183-190
